Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5
Open Access
Abstract
Galectin-3, which is a novel biomarker of cardiovascular stress and related to inflammation, could predict adverse cardiovascular events. However, its relationship with endothelial function in patients with chronic kidney disease (CKD) remains inconclusive. This study aimed to investigate the association between serum galectin-3 levels and endothelial function in patients with stages 3–5 CKD. Fasting blood samples were obtained from 130 patients. Serum galectin-3 levels were determined using the enzyme-linked immunosorbent assay. The endothelial function, demonstrated as a vascular reactivity index (VRI), was measured noninvasively through digital thermal monitoring test. Then, we sorted the patients into poor, intermediate, and good vascular reactivity (VRI < 1.0, 1.0 ≤ VRI < 2.0, and VRI ≥ 2.0), accounting for 24 (18.5%), 44 (33.8%), and 62 (47.7%) patients, respectively. As the VRI decreased, the serum galectin-3 and C-reactive protein (CRP) levels significantly increased. The galectin-3 value positively correlated with the CRP value but negatively correlated with estimated glomerular filtration rate. In multivariable stepwise linear regression analysis, serum log-transformed galectin-3 level and log-transformed CRP were significantly negatively associated with VRI values. Therefore, galectin-3 together with CRP is associated with VRI values and is a potential endothelial function modulator and a valuable biomarker of endothelial dysfunction in patients with CKD.Keywords
Funding Information
- Buddhist Tzu Chi Medical Foundation (TCRD109-87)
This publication has 34 references indexed in Scilit:
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Tubular Atrophy and Interstitial Fibrosis After Renal Transplantation Is Dependent on Galectin-3Transplantation, 2012
- Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and SurvivalThe American Journal of Cardiology, 2011
- Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney InjuryPLOS ONE, 2011
- Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosisAmerican Journal of Physiology-Renal Physiology, 2011
- All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in TaiwanThe Lancet, 2008
- Galectin-3 Is an Amplifier of Inflammation in Atherosclerotic Plaque Progression Through Macrophage Activation And Monocyte ChemoattractionArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric DimethylarginineAmerican Journal of Kidney Diseases, 2006
- Up-Regulation of Galectin-3 in Acute Renal Failure of the RatThe American Journal of Pathology, 2000
- Abnormalities of endothelial function in patients with predialysis renal failureHeart, 2000